[go: up one dir, main page]

ATE430573T1 - Pharmauzetisch zusammensetzung nitratenquelle und ansäuerungsmitteln enthaltende zur behandlung von offenen wunden und verbrennungen - Google Patents

Pharmauzetisch zusammensetzung nitratenquelle und ansäuerungsmitteln enthaltende zur behandlung von offenen wunden und verbrennungen

Info

Publication number
ATE430573T1
ATE430573T1 AT00907851T AT00907851T ATE430573T1 AT E430573 T1 ATE430573 T1 AT E430573T1 AT 00907851 T AT00907851 T AT 00907851T AT 00907851 T AT00907851 T AT 00907851T AT E430573 T1 ATE430573 T1 AT E430573T1
Authority
AT
Austria
Prior art keywords
treatment
pharmaucetic
acidificants
burns
source
Prior art date
Application number
AT00907851T
Other languages
English (en)
Inventor
Arthur Tudor Tucker
Nigel Benjamin
Original Assignee
Queen Mary & Westfield College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Queen Mary & Westfield College filed Critical Queen Mary & Westfield College
Application granted granted Critical
Publication of ATE430573T1 publication Critical patent/ATE430573T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
AT00907851T 1999-03-09 2000-03-09 Pharmauzetisch zusammensetzung nitratenquelle und ansäuerungsmitteln enthaltende zur behandlung von offenen wunden und verbrennungen ATE430573T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9905425.6A GB9905425D0 (en) 1999-03-09 1999-03-09 Pharmaceutical composition
PCT/GB2000/000853 WO2000053193A1 (en) 1999-03-09 2000-03-09 Pharmaceutical composition containing nitrate source and an acidifying agent for treating skin ischaemia

Publications (1)

Publication Number Publication Date
ATE430573T1 true ATE430573T1 (de) 2009-05-15

Family

ID=10849290

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00907851T ATE430573T1 (de) 1999-03-09 2000-03-09 Pharmauzetisch zusammensetzung nitratenquelle und ansäuerungsmitteln enthaltende zur behandlung von offenen wunden und verbrennungen

Country Status (11)

Country Link
US (3) US20020090401A1 (de)
EP (1) EP1161248B1 (de)
JP (1) JP5084985B2 (de)
AT (1) ATE430573T1 (de)
AU (1) AU2931500A (de)
DE (1) DE60042153D1 (de)
DK (1) DK1161248T3 (de)
ES (1) ES2326729T3 (de)
GB (1) GB9905425D0 (de)
PT (1) PT1161248E (de)
WO (1) WO2000053193A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030180379A1 (en) 2000-07-27 2003-09-25 Burrell Robert E. Solutions and aerosols of metal-containing compounds
US6780849B2 (en) 2000-12-21 2004-08-24 Scimed Life Systems, Inc. Lipid-based nitric oxide donors
EP2565157B1 (de) * 2001-09-05 2017-10-04 Geno LLC Stickoxid-erzeugung
AU2004257693B8 (en) 2003-07-09 2009-08-13 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US7618594B2 (en) 2004-08-18 2009-11-17 Geno Llc Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
CA2576957C (en) 2004-08-18 2013-04-02 Geno Llc Conversion of nitrogen dioxide (no2) to nitric oxide (no)
WO2006100154A1 (en) * 2005-03-24 2006-09-28 Nolabs Ab Cosmetic treatment with nitric oxide, device for performing said treatment and manufacturing method therefor
CA2606565C (en) 2005-05-27 2016-05-10 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
GB0607402D0 (en) 2006-04-12 2006-05-24 Barts & London Nhs Trust Therapeutic composition and use
WO2009006701A1 (en) * 2007-07-12 2009-01-15 Peter O'gorman Topical medicament
GB0715556D0 (en) * 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings
US9278157B2 (en) 2007-08-09 2016-03-08 Insense Limited Nitric oxide-generating skin dressings
WO2009055008A1 (en) * 2007-10-24 2009-04-30 Wharton Innovative Products, Llc Two part lotion for the delivery of nitrite ions to the skin
US8980332B2 (en) 2007-10-30 2015-03-17 The Invention Science Fund I, Llc Methods and systems for use of photolyzable nitric oxide donors
US10080823B2 (en) 2007-10-30 2018-09-25 Gearbox Llc Substrates for nitric oxide releasing devices
US8877508B2 (en) 2007-10-30 2014-11-04 The Invention Science Fund I, Llc Devices and systems that deliver nitric oxide
US9649334B2 (en) 2007-11-15 2017-05-16 The Uab Research Foundation Use of nitrite salts in chronic ischemia
JP2011507968A (ja) * 2007-12-27 2011-03-10 エイヤーズ ファーマシューティカルズ、インク． エアロゾル化ニトライトおよび一酸化窒素供与性化合物ならびにそれらの使用
AU2009209181B2 (en) 2008-01-28 2014-01-16 VERO Biotech LLC. Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
US8303995B1 (en) * 2008-06-13 2012-11-06 Board Of Regents, The University Of Texas System Nitrite formulations and their use as nitric oxide prodrugs
CA2728789A1 (en) * 2008-06-24 2009-12-30 Micropharma Limited Nitric oxide compositions and devices and methods for cosmesis
US8607785B2 (en) 2008-08-21 2013-12-17 Geno Llc Systems and devices for generating nitric oxide
US20120237617A1 (en) 2009-06-18 2012-09-20 Theravasc Inc. Use of nitrite salts in treating tissue damage
US8613958B2 (en) 2009-06-22 2013-12-24 Geno Llc Nitric oxide therapies
WO2011022652A1 (en) 2009-08-21 2011-02-24 Novan, Inc. Topical gels
WO2011022680A2 (en) 2009-08-21 2011-02-24 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
CN107260756A (zh) 2009-10-14 2017-10-20 瑟阿瓦斯克有限公司 亚硝酸盐/酯的药物制剂以及其应用
JP5995724B2 (ja) * 2009-11-20 2016-09-21 ゲノ エルエルシー 一酸化窒素送達システム
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118819A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same
BR112014003414B1 (pt) 2011-08-17 2021-09-21 Board Of Regents, The University Of Texas System Composição e sistema de entrega oral para aumento de níveis fisiológicos e terapêuticos de óxido nítrico
DK2958573T3 (da) 2013-02-20 2019-08-05 The Board Of Supervisors Of The Louisiana State Univ Mechanical And Agricultural College Farmaceutiske formuleringer af nitrit og anvendelser deraf
GB201309091D0 (en) 2013-05-20 2013-07-03 Edixomed Ltd Dressing system
GB201309092D0 (en) 2013-05-20 2013-07-03 Edixomed Ltd Transdermal delivery system
GB201420761D0 (en) 2014-11-21 2015-01-07 Edixomed Ltd And First Water Ltd Dressing system
TWI562038B (en) * 2015-07-08 2016-12-11 Wistron Corp Method of detecting touch position and touch apparatus thereof
GB201520990D0 (en) 2015-11-27 2016-01-13 Edixomed Ltd Dressing system
WO2020227367A1 (en) * 2019-05-06 2020-11-12 Pneuma Nitric Oxide, Llc Nitric oxide compositions and topical uses thereof
EP3980032A1 (de) 2019-06-04 2022-04-13 Thirty Respiratory Limited Verfahren und zusammensetzungen zur erzeugung von stickoxid und verwendungen davon zur abgabe von stickoxid über die atemwege
EP3980373A1 (de) 2019-06-04 2022-04-13 Thirty Holdings Limited Verfahren und zusammensetzungen zur erzeugung von stickstoffmonoxid und verwendungen davon
EP4138794A1 (de) 2020-04-23 2023-03-01 Thirty Respiratory Limited Verfahren und zusammensetzungen zur behandlung und bekämpfung von tuberkulose
GB2610722B (en) 2020-04-23 2024-07-31 Thirty Respiratory Ltd Nitric oxide or nitric oxide releasing compositions for use in treating SARS-COV and SARS-COV-2
US20240350409A1 (en) * 2023-04-20 2024-10-24 LifeActive, Inc. Transdermal delivery formulations and methods for the manufacture thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH629100A5 (de) * 1979-09-27 1982-04-15 Solco Basel Ag Hautpraeparat.
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
DE69324011T2 (de) * 1992-06-08 1999-10-07 Pitmy International N.V., Bonaire Distickstoffmonoxide enthaldendes dermatologisches präparat
US6709681B2 (en) * 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
KR100385297B1 (ko) * 1994-02-21 2003-10-10 에이버딘 유니버시티 항균제로서의산성화아질산염
US5648101A (en) * 1994-11-14 1997-07-15 Tawashi; Rashad Drug delivery of nitric oxide
JP3002772B2 (ja) * 1996-05-15 2000-01-24 マルホ株式会社 貼付剤及びその製造法
US6207713B1 (en) * 1997-09-17 2001-03-27 Eric T. Fossel Topical and oral delivery of arginine to cause beneficial effects
US5994444A (en) * 1997-10-16 1999-11-30 Medtronic, Inc. Polymeric material that releases nitric oxide
US6103275A (en) * 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide
US7404990B2 (en) * 2002-11-14 2008-07-29 Air Products And Chemicals, Inc. Non-thermal process for forming porous low dielectric constant films
US7056840B2 (en) * 2003-09-30 2006-06-06 International Business Machines Corp. Direct photo-patterning of nanoporous organosilicates, and method of use

Also Published As

Publication number Publication date
EP1161248A1 (de) 2001-12-12
US20080226751A1 (en) 2008-09-18
US20020090401A1 (en) 2002-07-11
GB9905425D0 (en) 1999-05-05
PT1161248E (pt) 2009-08-05
US20150004258A1 (en) 2015-01-01
EP1161248B1 (de) 2009-05-06
ES2326729T3 (es) 2009-10-19
DK1161248T3 (da) 2009-08-31
JP5084985B2 (ja) 2012-11-28
JP2002538210A (ja) 2002-11-12
DE60042153D1 (de) 2009-06-18
WO2000053193A1 (en) 2000-09-14
AU2931500A (en) 2000-09-28

Similar Documents

Publication Publication Date Title
ATE430573T1 (de) Pharmauzetisch zusammensetzung nitratenquelle und ansäuerungsmitteln enthaltende zur behandlung von offenen wunden und verbrennungen
ES2275716T3 (es) Composicion farmaceutica de liberacion transdermica.
MXPA02002895A (es) Tratamiento topico de infecciones por estreptococcus.
DE69727158D1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
ATE264685T1 (de) Angesäuertes nitrit zur verwendung als antimikrobielles mittel
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
MXPA02009904A (es) Derivados de apomorfina y metodos para su uso.
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
NZ513096A (en) Compositions for treating inflammatory response
ATE239709T1 (de) Racemisches huperzin a
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
BR0111989A (pt) Peptìdeos, composições e processos para o tratamento de burkholderia cepacia
DE69927584D1 (de) Pharmazeutische zubereitungen zur behandlung von magengeschwüren
ATE232390T1 (de) Osmotisches nicht-fermentiertes laxans zur behandlung und vorbeugung von kolorektalem krebs
AU3435189A (en) Topically applied gold organic complex
UY26426A1 (es) Nuevos compuestos
DE60320034D1 (de) Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
DE60207606D1 (de) Artikel zur wundbehandlung
ATE286890T1 (de) Biologisch wirksame, analoge verbindungen von discodermoliden
SE0000303D0 (sv) Novel compounds
DE69814691D1 (de) Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten
DE60135454D1 (de) Pharmazeutische gel-zusammensetzung
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE235909T1 (de) Biologisch kompatible und biologisch abbaubare zubereitungen enthaltend hyaluronsäure und deren derivate zur behandlung von geschwüren im verdauungsapparat
EA199800953A1 (ru) Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1161248

Country of ref document: EP